Proqr Therapeutics N V (PRQR)

10:57 AM

Is ProQR Therapeutics N.V. stock a growth or value playFree Real-Time Stock Data - Newser

10:57 AM

10:52 AM

When is ProQR Therapeutics N.V. stock expected to show significant growthInvest confidently with market-leading analysis - jammulinksnews.com

10:52 AM

09:52 AM

Is ProQR Therapeutics N.V. stock overvalued or undervaluedInvest smarter with daily market updates - jammulinksnews.com

09:52 AM

07:08 AM

Buy Signal for ProQR Therapeutics N.V. Stock Key Technical Indicators to WatchFree Investment Community - Newser

07:08 AM

06:53 AM

How ProQR Therapeutics N.V. stock performs during market volatilityFree Stock Market Strategy Classes - Newser

06:53 AM

06:14 AM

Why ProQR Therapeutics N.V. stock attracts strong analyst attentionBest Stocks for Capital Safety - Newser

06:14 AM

06:07 AM

ProQR Therapeutics N.V. Company Revenue and Profit Trends: A Deep DiveFree Stock Market Beginners Guide - Newser

06:07 AM

Jul 25, 2025

Is ProQR Therapeutics N.V. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

ProQR Therapeutics N.V. Stock Analysis and ForecastMarket-leading growth rates - Autocar Professional

Jul 25, 2025

Jul 25, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Jul 25, 2025

Jul 24, 2025

Will ProQR Therapeutics N.V. stock benefit from interest rate changesAccelerated financial growth - jammulinksnews.com

Jul 24, 2025

Jul 23, 2025

What drives ProQR Therapeutics N.V. stock priceStrong return on assets - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about ProQR Therapeutics N.V. stockUnprecedented profit potential - Autocar Professional

Jul 23, 2025

Jul 21, 2025

Owning 32% shares,institutional owners seem interested in ProQR Therapeutics N.V. (NASDAQ:PRQR), - Yahoo Finance

Jul 21, 2025

Jul 17, 2025

ProQR stock rating reiterated by Cantor Fitzgerald ahead of key 2H25 data - Investing.com Nigeria

Jul 17, 2025

Jul 15, 2025

What makes ProQR Therapeutics N.V. stock price move sharplyFree Wealth-Building Investment Strategies - Newser

Jul 15, 2025

Jul 15, 2025

ProQR Therapeutics N.V.'s (NASDAQ:PRQR) high institutional ownership speaks for itself as stock continues to impress, up 16% over last week - simplywall.st

Jul 15, 2025

Jul 14, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Shares Acquired by OneDigital Investment Advisors LLC - Defense World

Jul 14, 2025

Jul 11, 2025

ProQR Therapeutics (NASDAQ:PRQR) Stock Price Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat

Jul 11, 2025

Jul 10, 2025

Vontobel Holding Ltd. Invests $48,000 in ProQR Therapeutics N.V. (NASDAQ:PRQR) - Defense World

Jul 10, 2025

Jul 07, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles - Investing.com Australia

Jul 07, 2025

Jul 06, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles By Investing.com - Investing.com South Africa

Jul 06, 2025

Jul 03, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts - MarketBeat

Jul 03, 2025

Jun 30, 2025

ProQR Therapeutics' (PRQR) "Market Outperform" Rating Reaffirmed at JMP Securities - MarketBeat

Jun 30, 2025

Jun 28, 2025

ProQR Therapeutics (NASDAQ:PRQR) Given Market Outperform Rating at JMP Securities - Defense World

Jun 28, 2025

Jun 27, 2025

PRQR: Cantor Fitzgerald Reiterates Overweight Rating | PRQR Stoc - GuruFocus

Jun 27, 2025

Jun 27, 2025

ProQR stock advances as Cantor Fitzgerald reaffirms $8 price target By Investing.com - Investing.com Canada

Jun 27, 2025

Jun 27, 2025

ProQR stock advances as Cantor Fitzgerald reaffirms $8 price target - Investing.com

Jun 27, 2025

Jun 26, 2025

ProQR submits clinical trial application for RNA editing therapy By Investing.com - Investing.com India

Jun 26, 2025

Jun 26, 2025

ProQR Seeks EU Approval for Liver Cell Protein Trial - MarketScreener

Jun 26, 2025

Jun 26, 2025

ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP - GlobeNewswire

Jun 26, 2025

Jun 26, 2025

ProQR Advances First RNA Editing Therapy to Clinical Trials for Liver Disease | PRQR Stock News - Stock Titan

Jun 26, 2025

Jun 15, 2025

Bank of America Corp DE Boosts Position in ProQR Therapeutics (NASDAQ:PRQR) - Defense World

Jun 15, 2025

Jun 13, 2025

ProQR Therapeutics N.V. (NASDAQ:PRQR) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected - simplywall.st

Jun 13, 2025